Filippini - Ingliż - FDA (Food And Drug Administration)

pt sandoz indonesia; importer: sandoz philippines corporation - fenofibrate - capsule - 100 mg

Tanżanija - Ingliż - Tanzania Medicinces & Medical Devices Authority

bahari pharmacy limited, tanzania - pregabalin - capsules - 150 mg

Filippini - Ingliż - FDA (Food And Drug Administration)

unilab, inc.; distributor: unilab, inc. - multivitamins , minerals - softgel capsule - formulation: each softgel capsule contains retinol palmitate (vitamin a) dl-alpha tocopheryl acetate (vitar ascorbic acid (vitamin c) zinc (as sulfate) 5,000 iu 100 iu 500 mg 25 mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: carmellose calcium; magnesium stearate; carmine; lactose monohydrate; hypromellose; gelatin; titanium dioxide; glycerol - 1. angina pectoris, 2. hypertension, 3. prevention of migraine, 4. cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (e.g. tachycardia due to digitalis or adrenaline overdosage), 5. essential tremor, including familial and senile tremor, 6.phaeochromocytoma (only with concurrent alpha-receptor blockade), 7. hypertrophic subaortic stenosis, 8. suspected or definite myocardial infarction, 9. fallot's tetralogy.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: carmellose calcium; carmine; magnesium stearate; gelatin; hypromellose; glycerol; titanium dioxide; lactose monohydrate - indications as at 05 mar 02 : 1. angina pectoris, 2. hypertension, 3. prevention of migraine, 4. cardiac dysrhythmias : certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (e.g. tachycardia due to digitalis or adrenaline overdosage), 5. essential tremor, including familial and senile tremor, 6.phaeochromocytoma (only with concurrent alpha-receptor blockade), 7. hypertrophic subaortic stenosis, 8. suspected or definite myocardial infarction, 9. fallot's tetralogy.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

astrazeneca limited - propranolol hydrochloride 160mg - modified release capsule - 160 mg - active: propranolol hydrochloride 160mg excipient: erythrosine ethylcellulose gelatin hypromellose iron oxide black iron oxide red microcrystalline cellulose titanium dioxide

Kanada - Ingliż - Health Canada

ayerst laboratories - propranolol hydrochloride - capsule (sustained-release) - 160mg - propranolol hydrochloride 160mg - beta-adrenergic blocking agents

Kanada - Ingliż - Health Canada

ayerst laboratories - propranolol hydrochloride - capsule (sustained-release) - 80mg - propranolol hydrochloride 80mg - beta-adrenergic blocking agents

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - propranolol hydrochloride -

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

pco manufacturing - propranolol hydrochloride - prolonged release capsules - 80